← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Guild Associates, Inc.
Dublin, OH
$12,705,105
Total funding
19
Grants
Funding over time
peak $1.6M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$12,705,105 · 19
By mechanism
R01$6,314,108 · 2
N43$1,653,431 · 6
R44$1,429,022 · 2
R33$1,282,224 · 1
R43$1,067,627 · 6
R21$958,693 · 2
Investigators at Guild Associates, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
All-Time
Most funded here, all years
Largest grants
Rapid multiplex method for direct phenotypic ID/AST of bacterial pathogens$1,230,698
R01 · FY2018 · AI
Rapid multiplex method for direct phenotypic ID/AST of bacterial pathogens$1,203,777
R01 · FY2019 · AI
Rapid multiplex method for direct phenotypic ID/AST of bacterial pathogens$1,168,045
R01 · FY2020 · AI
Rapid multiplex method for direct phenotypic ID/AST of bacterial pathogens$1,158,336
R01 · FY2021 · AI
Detection of Biodefense Pathogens Using Phage Diagnostics$745,386
R01 · FY2015 · AI
Detection of Biodefense Pathogens Using Phage Diagnostics$472,829
R01 · FY2014 · AI
Bioluminescent reporter phage for the diagnostic detection of shigellosis$452,658
R33 · FY2015 · AI
Bioluminescent reporter phage for the diagnostic detection of shigellosis$429,553
R33 · FY2014 · AI
Bioluminescent reporter phage for the diagnostic detection of shigellosis$400,013
R33 · FY2016 · AI
Phage-mediated bioluminescent detection of Yersinia pestis$395,287
R44 · FY2011 · AI
In vivo profiling for oral candidiasis drug target discovery$394,339
R44 · FY2009 · DE
Detection of Biodefense Pathogens Using Phage Diagnostics$335,037
R01 · FY2016 · AI
In vivo profiling for oral candidiasis drug target discovery$330,143
R44 · FY2010 · DE
Phage-mediated bioluminescent detection of Yersinia pestis$309,253
R44 · FY2012 · AI
Point-of-Care and Pharmacy-based Antiretroviral Drug Adherence Assays$306,718
N43 · FY2025 · DA
ANTI-TUBERCULOSIS ANTIBIOTIC QUANTIFICATION$299,999
N43 · FY2019 · AI
NIMH SBIR PHASE I TOPIC 001- POINT-OF-CARE HIV VIRAL LOAD AND DRUG ADHERENCE ASSAYS$299,976
N43 · FY2024 · DA
Point-of-Care Electrochemical Aptasensor for Long-Term Pharmacological Adherence Monitoring$299,971
N43 · FY2023 · AI
Phage-accelerated test system for ID/AST of urinary tract infections$291,129
R43 · FY2017 · AI
Bioluminescent reporter phage for the diagnostic detection of shigellosis$290,396
R21 · FY2012 · AI